NCT03923114View on ClinicalTrials.gov

Imaging Pituitary ActiVation by Exendin

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
RADIATION

Ga-68-NODAGA-exendin-4 PET/CT

PET/CT imaging after injection with Ga-68-NODAGA-exendin-4

Trial Locations (1)

6525 GA

Radboud university medical center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT03923114 - Imaging Pituitary ActiVation by Exendin | Biotech Hunter | Biotech Hunter